Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules
Abstract Background Myeloid derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) are two of the major players involved in the inhibition of anti-tumor immune response in cancer patients, leading to poor prognosis. Selective targeting of myeloid cells has therefore become an attra...
Main Authors: | Laura Pinton, Sara Magri, Elena Masetto, Marina Vettore, Ilaria Schibuola, Vincenzo Ingangi, Ilaria Marigo, Kevin Matha, Jean-Pierre Benoit, Alessandro Della Puppa, Vincenzo Bronte, Giovanna Lollo, Susanna Mandruzzato |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12951-020-00589-3 |
Similar Items
-
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
by: Elisa Peranzoni, et al.
Published: (2020-07-01) -
Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma
by: Laura Pinton, et al.
Published: (2018-07-01) -
Swertianolin ameliorates immune dysfunction in sepsis <em>via</em> blocking the immunosuppressive function of myeloid- derived suppressor cells
by: Zongfang Ren, et al.
Published: (2021-09-01) -
Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment
by: Eric Jou, et al.
Published: (2024-02-01) -
Mechanisms underlying immunosuppression by regulatory cells
by: Oliver Goldmann, et al.
Published: (2024-02-01)